Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of ...
The tablets were shipped out across the U.S., though Aurobindo didn’t specify where the products were manufactured. Glenmark Pharmaceuticals, for its part, issued voluntary recalls for 90,528 ...
Glenmark Pharmaceuticals reported a second-quarter profit on Thursday, helped by strong demand for its drugs that treat long-term illnesses. India's Glenmark Pharma posts Q2 profit on strong ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback